Traws Pharma, Inc. (TRAW)
Data as of , from SEC Form 4 filings.
See up to 3 months of TRAW. The 7-day demo opens the 1M and 3M ranges and puts TRAW on your watchlist.
Start 7-day demoLatest TRAW insider trades
About Traws Pharma, Inc. (TRAW)
The SEC lists Traws Pharma, Inc. under CIK 0001130598, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TRAW Form 4 activity by transaction type, last 90 days
No Form 4 activity for TRAW in the last 90 days.
TRAW insider transactions (Form 4)
1645 Form 4 filings on record, the earliest from Apr 2, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Harold Leaman | Grant or award | Stock Option (right to purchase) | 12,770 | $0.00 | - | |
| Robert Redfield - Officer | Grant or award | Stock Option (right to purchase) | 32,406 | $0.00 | - | |
| Charles David Pauza - Officer | Grant or award | Stock Option (right to purchase) | 32,406 | $0.00 | - | |
| Nikolay Savchuk - Officer | Grant or award | Stock Option (right to purchase) | 22,435 | $0.00 | - | |
| Trafford Clarke | Grant or award | Stock Option (right to purchase) | 11,530 | $0.00 | - | |
| Mary Teresa Shoemaker | Grant or award | Stock Option (right to purchase) | 11,530 | $0.00 | - | |
| Iain D. Dukes - Officer | Grant or award | Stock Option (right to purchase) | 64,839 | $0.00 | - | |
| Werner Cautreels | Grant or award | Stock Option (right to purchase) | 11,530 | $0.00 | - | |
| Jack E. Stover | Grant or award | Stock Option (right to purchase) | 11,530 | $0.00 | - | |
| John Harold Leaman | Grant or award | Stock Option (right to purchase) | 15,609 | $0.00 | - | |
| Trafford Clarke | Grant or award | Stock Option (right to purchase) | 23,000 | $0.00 | - | |
| Jack E. Stover | Grant or award | Stock Option (right to purchase) | 23,000 | $0.00 | - | |
| Mary Teresa Shoemaker | Grant or award | Stock Option (right to purchase) | 23,000 | $0.00 | - | |
| Werner Cautreels | Grant or award | Stock Option (right to purchase) | 23,000 | $0.00 | - | |
| TPAV, LLC - 10% Owner | Other | Common Stock | 605,531 | - | - | |
| TPAV, LLC - 10% Owner | Other | Series C Preferred Stock | 2,264 | $0.00 | - |
TRAW insider trading FAQ
What is the latest insider trade for TRAW?
Traws Pharma, Inc. (TRAW) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-16. The full record for TRAW runs to 45 Form 4 filings, the earliest from 2025-04-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TRAW stock?
No insider purchases of TRAW were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling TRAW stock?
No insider sales of TRAW were filed in the last 90 days.
Where can I see TRAW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TRAW Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Charles David Pauza view on EDGAR
- - Werner Cautreels view on EDGAR
- - Nikolay Savchuk view on EDGAR
- - Jack E. Stover view on EDGAR
- - Iain D. Dukes view on EDGAR
- - Robert Redfield view on EDGAR
- - Charles Nolan Parker view on EDGAR
- - Mary Teresa Shoemaker view on EDGAR
- - Trafford Clarke view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TRAW's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TRAW with a 7-day demo
- TRAW on your watchlist
- Every TRAW Form 4 filing on record
- Up to 3 months of TRAW price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
